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The PilE pilin subunit protein of Neisseria gonorrhoeae undergoes unique covalent modifications with
phosphoethanolamine (PE) and phosphocholine (PC). The pilin phospho-form transferase A (PptA) protein,
required for these modifications, shows sequence relatedness with and architectural similarities to lipopoly-
saccharide PE transferases. Here, we used regulated expression and mutagenesis as means to better define the
relationships between PptA structure and function, as well as to probe the mechanisms by which other factors
impact the system. We show here that pptA expression is coupled at the level of transcription to its distal gene,
murF, in a division/cell wall gene operon and that PptA can act in a dose-dependent fashion in PilE phospho-
form modification. Molecular modeling and site-directed mutagenesis provided the first direct evidence that
PptA is a member of the alkaline phosphatase superfamily of metalloenzymes with similar metal-binding sites
and conserved structural folds. Through phylogenetic analyses and sequence alignments, these conclusions
were extended to include the lipopolysaccharide PE transferases, including members of the disparate Lpt6
subfamily, and the MdoB family of phosphoglycerol transferases. Each of these enzymes thus likely acts as a
phospholipid head group transferase whose catalytic mechanism involves a trans-esterification step generating
a protein-phospho-form ester intermediate. Coexpression of PptA with PilE in Pseudomonas aeruginosa resulted
in high levels of PE modification but was not sufficient for PC modification. This and other findings show that
PptA-associated PC modification is governed by as-yet-undefined ancillary factors unique to N. gonorrhoeae.
Zwitterionic phospho-forms are increasingly being recog-
nized as influential substituents of pathogenic and commensal
microbe cell surfaces. Phosphoethanolamine (PE) modifica-
tion of lipopolysaccharide (LPS) has been documented in a
number of important pathogens (3, 13, 23, 38, 57) and has been
implicated in resistance to cationic microbial peptides (24, 53)
and recognition by complement component C4b (34). Phos-
phocholine (PC) modification of LPS is documented in Hae-
mophilus influenzae and commensal Neisseria species (25, 42),
while in Streptococcus pneumoniae, PC is found covalently
linked to teichoic/lipoteichoic acid, as well as to some capsular
polysaccharides (55). Activities ascribed to the PC moiety
found in LPS, teichoic/lipoteichoic acids, and complex oligo-
saccharides include enhancing epithelial and endothelial cell
adherence through binding to the receptor for platelet-activat-
ing factor (7, 41, 51) and acting as a ligand for C-reactive
protein (41, 60) and PC-recognizing antibodies (4). The PilE
protein subunit of the Neisseria gonorrhoeae type IV pilus (Tfp)
colonization factor can be uniquely modified by the covalent
addition of PE, as well as PC, to select serine residues (1, 14).
This situation thus contrasts with all other examples noted, in
which PE and PC are exclusively linked through carbohydrate
moieties.
Given their increasing recognition as biologically active sub-
stituents, heightened attention has been focused on char-
acterizing biosynthetic pathways involved in zwitterionic phos-
pho-form modifications. Phospholipid headgroups represent
abundant and conveniently localized donor sources for such
phospho-form modifications. The Escherichia coli EptB pro-
tein (formerly called YhjW) has been shown to be directly
responsible for modifying the inner core of LPS with PE, using
phosphatidylethanolamine as a precursor (35). Most gram-
negative species possess multiple genes whose products show
structural homology to EptB. They include the Salmonella
enterica gene cptA (53) and pmrC (24), as well as lptA (6) and
the Lpt3 (26) and Lpt6 (70) genes from Neisseria meningitidis.
Although phosphatidylcholine is found in significant amounts
in diverse groups of bacteria, there are as yet no known in-
stances in which its head group serves as a precursor. Rather,
PC modifications of both LPS and teichoic/lipoteichoic acids
involve a CDP-choline-type pathway utilizing enzymes en-
coded by the lic genes (61, 71) that requires exogenous choline
or choline-containing compounds as precursors. Although
present in commensal Neisseria species, the lic genes are absent
in both N. gonorrhoeae and N. meningitidis. We recently iden-
tified PptA as a putative pilin phospho-form transferase re-
quired for modification of N. gonorrhoeae PilE with both PE
and PC (1). The orthologous N. meningitidis PptA protein was
implicated early on in PC modification of pilin, as high-fre-
quency frame-shifting events within pptA correlated with phase
(on-off) variation of the PilE PC epitope (58). PptA shares
multiple structural features with E. coli EptB and related pro-
teins implicated in LPS PE modification, which are all grouped
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together in the so-called YhjW/YjdB/YijP family, which com-
prises a subfamily of the larger alkaline phosphatase superfam-
ily. The members of this superfamily have conserved core
structures and active-site residues, which has led to the pro-
posal that these enzymes involve catalytic cycles of phos-
phorylation, sulfatation, or phosphonation of conserved Ser/
Cys/Thr residues (12). It has also been suggested that these
enzymes have the same reaction scheme as was originally pro-
posed for E. coli alkaline phosphatase (AlkP) (21).
The structural relatedness of PptA with EptB and other LPS
PE transferases likely utilizing phosphatidylethanolamine as a
donor strongly suggests similar modes of action. However, phos-
phatidylcholine has been documented only once in N. gonor-
rhoeae (49), while a more recent study of gonococcal phospholip-
ids using fast atom bombardment-mass spectrometry (MS) and
gas liquid chromatography-MS technologies failed to detect its
presence (33). Two bacterial pathways for phosphatidylcholine
synthesis have been characterized in bacteria: one in which en-
dogenous phosphatidylethanolamine undergoes methylation by
phospholipid N-methyltransferases and another in which it is syn-
thesized via direct condensation of exogenous choline with CDP-
diacylglyceride mediated by the activity of phosphatidylcholine
synthase (46). To date, no phospholipid N-methyltransferases or
phosphatidylcholine synthase orthologs are readily identifiable
within neisserial genome sequences.
An additional confounding factor in pilin phospho-form
modification involves the pilin-like PilV protein. Pilin PC mod-
ification has been seen only in pilV null mutants, a background
that is also associated with PE hypermodification while PilV
overexpression is associated with PE hypomodification (1).
The mechanisms by which PilV impacts each of these aspects
of Tfp biology remain enigmatic.
The goal of this study was to characterize pptA in regard to
its genetic organization and to probe the structure-function
relationships of PptA, as well as to gain insight into the rela-
tionships between PE and PC modifications mediated by PptA.
MATERIALS AND METHODS
Bacterial strains, vectors, and culture conditions. The bacterial strains used in
this study are described in Table 1. N. gonorrhoeae strains were grown on
conventional GC medium as described previously (9) unless otherwise described
as grown on defined, choline-free medium (30). E. coli DH5 or HB101 was used
for plasmid propagation and cloning experiments and was grown on Luria-
Bertani (LB) medium (37). The antibiotics used for selection of transformants
and transconjugants were at the following concentrations: in N. gonorrhoeae,
chloramphenicol, 10 g/ml, and erythromycin, 8 g/ml; in E. coli, chloramphen-
icol, 30 g/ml; erythromycin, 300 g/ml; kanamycin, 50 g/ml; ampicillin, 100
g/ml; tetracycline, 15 g/ml; and streptomycin, 100 g/ml; in Pseudomonas
aeruginosa PAK, carbenicillin, 1,000 g/ml, and kanamycin, 1,000 g/ml. For
growth of P. aeruginosa PAK, the concentrations of carbenicillin and kanamycin
were reduced to 300 g/ml. Isolation and purification of plasmid DNA were
performed by using QIAprepSpin Miniprep columns (no. 27106) according to
the manufacturer’s specifications (Qiagen, Chatsworth, CA). The nucleotide
sequences of all clones and constructs described were determined from plasmid
DNA or directly from PCR products derived from N. gonorrhoeae mutant strains
at GATC Biotech AG (Konstanz, Germany).
Construction of an N. gonorrhoeae pptA null mutant and strains carrying
site-specific mutations. The pptA::kan allele carried on plasmid pLS3 (44) was
introduced into the wt strain N400 and into GV1 [pilV(Fs) (a null allele of pilV
with a frameshift mutation at the G1 codon (65)], by transformation and
selection for kanamycin-resistant transformants, to generate the pptA null mu-
tants designated KS9 (pptA::kan) and KS10 [pilV(Fs) pptA::kan]. The strains
carrying the pptALS1::kan allele carried on plasmid pLS1 (44) have been previ-
ously described (1).
The pptA gene was amplified from genomic DNA from the N. gonorrhoeae
strain N400 with the primers pptA5 and pptA3. The resulting PCR fragment
was digested with restriction endonucleases cutting at EcoRI and BamHI (see
Table S1 in the supplemental material) and cloned into the polylinker of the
plasmid pUP6 (67), yielding plasmid pUP6 pptA. Point mutations in pptA were
made by using a modified version of the PCR-based technique termed splicing by
overlap extension (SOE). The SOE PCR products were subcloned into pUP6
pptA, and new restriction sites created by the point mutation were used for
screening. For the point mutations listed in Table S1 in the supplemental ma-
terial, the two PCR products for each site-specific mutation were subjected to
SOE using the flanking primers pptA51150 and pptA31927 and cut with
BsteEII and NsiI (521 bp). The resulting fragment was then ligated with the
NsiI/NheI (2,009-bp)- and the BstEII/NheI (2,509-bp)-cut fragments of pUP6
pptA. For pptA(G239A), the upstream region was amplified using primers
G239A5 and pptA3, whereas the downstream primers were pptA5 and
G239A3. The two PCR products were spliced together using the flanking prim-
ers pptA5747 and pptA3. The resulting PCR fragment was cut with XmnI and
BstEII and ligated with the XmnI/NheI- and the BstEII /NheI-cut fragments of
pUP6 pptA, resulting in pUP6 pptA(G239A). The G239A mutation created a
unique DdeI restriction site. The following point mutations were made by sub-
cloning SOE PCR products into pUP6 pptA(G239A) and screening for loss of the
DdeI restriction site: pUP6 pptA(S241A) was made using PCR products from
S241A5 plus pptA3 and pptA5 plus S241A3; pUP6 pptA(241A) was made
using PCR products from S241_5 plus pptA3 and pptA5 plus S241_3.
All resulting plasmids were introduced into strain GV1 [pilV(Fs)] for further
analysis. pUP6 pptA(804) (see below) was cut with the restriction endonucleases
AdhI and NotI, and the fragment was transformed into KS25 and KS22 in order
to rescue the phenotype of the pptA(H436) and pptA(H379) point mutations.
Expression of pptA from an inducible promoter. To create an isopropylthio-
galactoside (IPTG)-regulatable pptA construct, the NotI-blunted fragment of
pVD300 recA6 carrying lacIq, the tandem lac operator promoter sequences
tacOP and UV5OP, and the tetM gene (39) was inserted into the HpaI site of
pUP6 pptA. The resulting plasmid was cut with XhoI and BamHI, and the 3
recessed ends were filled in using Klenow (New England BioLabs Inc.). The
resulting fragment containing lacIOP pptA was inserted into the SacI site (filled
in using Klenow) of p2/16/1 (67), resulting in p2/16/1 pptA(Ind).
Transposon mutagenesis of the pptA locus. The two target plasmids, pUP6
pptA(1315) and pUP6 pptA(804), were constructed by amplifying the pptA gene
in overlapping fragments from N. gonorrhoeae strain N400. The first 894 bp of
pptA, along with 421 bp upstream of the gene, were amplified using the primers
pptA5 and pptA1315_3. The terminal 1,327 bp of pptA, along with 227 bp
downstream of the gene, were amplified using primers dca804_5 and pptA3.
The resulting PCR fragments were digested with unique flanking EcoRI and
BamHI sites (see Table S1 in the supplemental material) and cloned into the
polylinker of the plasmid pUP6, yielding plasmids pUP6 pptA(1315) and pUP6
pptA(804), respectively. Transposon mutagenesis was performed on pUP6
pptA(1315) and pUP6 pptA(804) as described previously (40). Transposon inser-
tions were isolated, sequenced, and transformed into the gonococcal strain N400
as previously described (9).
P. aeruginosa strains and construction of mutants. The P. aeruginosa mutants
used in this study were derived from the wt strain PAK (52). Construction of the
pilA null allele was previously described (18), as were constructs for the pilT and
pilB mutations (50). The pilY1 null allele was assembled by removing an internal
fragment of coding sequence (amino acids 7 to 1094) from the targeted gene by
SOE PCR to generate a nonpolar in-frame deletion. Specific primer sequences
are available upon request. Deletion alleles were cloned into the suicide vector
pEXGmGW (68) and introduced onto the chromosome of strain PAK as de-
scribed previously (16). All deletions were confirmed by PCR and sequencing of
the relevant chromosomal regions.
Conjugation of plasmids into P. aeruginosa PAK. E. coli S17.1 (Table 1) was
used as a donor for conjugation of plasmids into P. aeruginosa PAK strains.
Donor and recipient strains were grown in LB broth at 37°C to an optical density
at 600 nm (OD600) of 0.4 to 0.8, and 1 ml of each was mixed in a centrifuge tube
and pelleted. The cells were resuspended in 100 l LB medium and deposited as
a drop on LB agar overnight at 37°C. The resulting growth was diluted in 6 ml
of LB medium, and 10 to 1,000 dilutions were plated onto pseudomonas
isolation agar (Difco) with the appropriate antibiotics.
Expression of PilE and PptA in P. aeruginosa PAK and E. coli. To express
gonococcal PilE in E. coli and P. aeruginosa, a Bsu36I/SmaI-blunted fragment
from pPilE2 (1) was ligated into pMMB67EH (10), cut with SmaI, and trans-
formed into E. coli DH5 and S17.1, respectively. The plasmid in S17.1 was
transferred to KS32 by conjugation. To express gonococcal PptA in E. coli and
KS32, an NdeI restriction site was fused to the ATG start codon of pptA by SOE
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PCR, using pUP6 pptA as a template. The upstream region was amplified using
primers pUP6_5 and pptA_NdeI_3, whereas the downstream primers were
pptA_NdeI_5 and pptA31000. The two PCR products were subjected to SOE
together, using flanking primers pUP6_5 and pptA31000. The resulting PCR
fragment was digested with restriction endonucleases recognizing the unique
EcoRI and BsgI sites and subcloned into pUP6 pptA cut with the same restriction
enzymes, yielding plasmid pUP6 pptAM1NdeI, which was then cut at the unique
NdeI and BamHI restriction sites. The resulting fragment was cloned into the
polylinker of pJT19 (64), yielding plasmid pJT19 pptA. This plasmid was trans-
formed into E. coli DH5 and S17.1, respectively, using S17.1 to transfer the
plasmid into KS32 by conjugation. For induction of PilE and PptA in E. coli and
KS32, the bacteria were grown to an OD660 of 0.8 and induced with 0.4 mM
TABLE 1. Strains used in this study
Strain Parentalstrain Relevant genotype Reference
N. gonorrhoeae
VD300a MS11 22
N400 VD300 recA6b 56
GV1 N400 pilV(Fs) 65
GE68 N400 pilE(S68A) 1
GE68V GE68 pilE(S68A) pilV(Fs) 1
KS1 GV1 pilV(Fs) pptA::Tn5 This study
KS2 GV1 pilV(Fs) pptA::Tn9 This study
KS3 GV1 pilV(Fs) pptA::Tn11 This study
KS4 GV1 pilV(Fs) pptA::Tn22 This study
KS5 N400 pptA::Tn5 This study
KS6 N400 pptA::Tn9 This study
KS7 N400 pptA::Tn11 This study
KS8 N400 pptA::Tn22 This study
KS9 N400 pptA::kan 44
KS10 GV1 pilV(Fs) pptA::kan This study
GD2 N400 pptALS1::kan 44
GD3 GV1 pilV(Fs) pptALS1::kan 1
KS11 KS10 pilV(Fs) pptA::kan iga::pptA(Ind) This study
KS12 KS5 pptA::Tn5 iga::pptA(Ind) This study
KS13 KS1 pilV(Fs) pptA::Tn5 iga::pptA(Ind) This study
KS14 KS11 pilV(Fs) pptA::kan iga::pptA(Ind)::Tn7 This study
KS15 KS11 pilV(Fs) pptA::kan iga::pptA(Ind)::Tn23 This study
KS16 GV1 pilV(Fs) pptA(S241A) This study
KS17 GV1 pilV(Fs) pptA(S241) This study
KS18 GV1 pilV(Fs) pptA(G239A) This study
KS19 GV1 pilV(Fs) pptA(H374A) This study
KS20 GV1 pilV(Fs) pptA(G377A) This study
KS21 GV1 pilV(Fs) pptA(S378A) This study
KS22 GV1 pilV(Fs) pptA(H379A) This study
KS23 GV1 pilV(Fs) pptA(S434A) This study
KS24 GV1 pilV(Fs) pptA(D435A) This study
KS25 GV1 pilV(Fs) pptA(H436A) This study
KS26 GV1 pilV(Fs) iga::pptA This study
KS27 KS10 pilV(Fs) pptA::kan iga::pptA This study
KS28 N400 iga::pptA(Ind) This study
KS29 KS9 pptA::kan iga::pptA(Ind) This study
KS30 GE68 pilE(S68A) iga::pptA(Ind) This study
KS31 GE68V pilV(Fs) pilE(S68A) iga::pptA(Ind) This study
P. aeruginosa
PAKpilA pilA 18
KS32 PAKpilA pilA pilT This study
KS33 KS32 pilA pilT pMMB67EH pilE This study
KS34 KS33 pilA pilT pMMB67EH pilE pJT19 pptA This study
KS35 KS32 pilA pilT pMMB67EH pilE(S68A) This study
KS36 KS32 pilA pilT pilY1 This study
KS37 KS36 pilA pilT pilY1 pMMB67EH pilE This study
KS38 KS37 pilA pilT pilY1 pMMB67EH pilE pJT19 pptA This study
KS39 KS32 pilA pilT pilB This study
KS40 KS39 pilA pilT pilB pMMB67EH pilE This study
KS41 KS40 pilA pilT pilB pMMB67EH pilE pJT19 pptA This study
E. coli
S17.1 RP4 2-Tc::Mu-Km::Tn7 pro res mod 43
KS42 DH5 pMMB67EH pilE This study
KS43 KS42 pMMB67EH pilE pJT19 pptA This study
a VD300 is an Opa derivative of MS11.
b recA6 is an IPTG-inducible allele of recA.
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IPTG and 2 mM m-toluate, respectively, for 2 hours. The cells were spun at 4,000
 g for 20 min, and the cell pellets were used for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and MS (see below).
Immunofluorescence microscopy, SDS-PAGE, and immunoblotting. For im-
munofluorescence microscopy, immobilization of bacteria was performed by
incubating 100 l of gonococcal cells at an OD660 of 0.1 for 1 h at 37°C in GC
medium on poly-L-lysine-coated glass coverslips and fixing them for 1 h with 2%
formaldehyde in phosphate-buffered saline. After being washed three times for
5 min each time in phosphate-buffered saline, the gonococci were labeled using
a 1:10 dilution of MicroTrak Neisseria gonorrhoeae Culture Conformation Test
according to the manufacturer’s specifications (Trinity Biotech PIc) and
mounted in the supplied mounting fluid before being viewed in a Nikon Eclipse
C400 fluorescence microscope.
The procedures for SDS-PAGE and immunoblotting have been described
previously (9). PC-decorated proteins were detected by using a 1:1,000 dilution
of the monoclonal antibody (MAb) TEPC-15 (Sigma) and alkaline phosphatase-
conjugated goat anti-mouse immunoglobulin A (Sigma) (14). PilE, PilV, and
PptA were detected by immunoblotting of whole-cell lysates, using rabbit poly-
clonal antibodies and alkaline phosphatase-coupled goat anti-rabbit antibodies
(Tago Inc.). PilV-specific sera have been described previously (65). PilE-specific
antisera were generated against isolated pili from N. gonorrhoeae strain N400
(Invitrogen [lot 904]). PptA-specific sera were generated and affinity purified
against recombinant His-tagged protein (Agrisera AB, Sweden). The recombi-
nant His-tagged protein encompassed amino acids 230 to 548 of PptA and was
amplified from N. gonorrhoeae strain N400 with primers pptA:sulfatase5 and
pptA:sulfatase3. The resulting PCR fragment was digested using restriction
endonucleases cutting at the unique, flanking BamHI and HindIII sites (see
Table S1 in the supplemental material) and cloned into the polylinker of the
plasmid pQE30 (Qiagen), resulting in the plasmid pQE30 pptA, which was
transformed into E. coli strain M15[pREP4]. For protein purification, 6 liters of
LB medium was inoculated with M15[pREP4] pQE30 pptA and was first incu-
bated for 4 h to approximately an OD600 of 1.3 before induction with 1 mM IPTG
and further incubation for 2 h to approximately an OD600 of 1.9. The cells were
harvested at 4,000  g for 20 min and frozen in liquid nitrogen. The frozen cells
were lysed using an X-press French press (AB BIOX, Sweden) and dissolved in
100 ml 20 mM NaH2PO4-20 mM Na2HPO4 with 5 mg DNase I added. The
suspension was agitated for 10 min, and urea was directly added to a final
concentration of 8 M and stirred until it completely dissolved. Cellular debris was
removed by centrifugation at 20,000 rpm in a JA25-50 rotor for 90 min, and the
supernatant was filtered through a 0.22-m filter (Millipore). The filtered solu-
tion was applied to a 5-ml Hitrap Chelating Histrap column mounted on an
ÁKTApurifier FPLC (Amersham Biosciences). The column was washed twice
with wash buffer 1 (20 mM NaH2PO4, 20 mM Na2HPO4, 8 M urea) and wash
buffer 2 (20 mM NaH2PO4, 20 mM Na2HPO4, 8 M urea, 10 mM imidazole). The
protein was then removed from the column by using an elution buffer (20 mM
NaH2PO4, 20 mM Na2HPO4, 8 M urea, 0.5 M imidazol). The fractions contain-
ing the recombinant PptA protein were concentrated through an Amicon Ultra
12 MWCO 30,000 centrifugal filter (Millipore) and applied to a Tricorn Super-
dex high-performance column (Superdex 200 10/300 GL; Amersham Bio-
sciences) with baseline separation. The fractions with PptA were concentrated
through a Centricon 10 centrifugal filter (Millipore) for 3 h at 5,000  g and
diluted in 20 mM Tris, pH 7.4, 4 M urea.
Quantitative real-time RT-PCR. RNA was isolated from N. gonorrhoeae using
Trizol (Invitrogen) according to the manufacturer’s instructions. The RNA was
purified using an RNeasy minikit (Qiagen) with the RNase-free DNase set
(Qiagen) according to the manufacturer’s instructions. Ten nanograms of RNA
was reverse transcribed and used as a template for quantitative real-time reverse
transcription (RT)-PCR on a Light Cycler (Roche) in the same reaction, using a
Quantitect Sybr green RT-PCR kit (Roche). The cycler conditions were the same
for all reactions; 57°C was used as the annealing temperature, and fluorescence
was read at 81°C. The primers used as the loading control were tbpA5 and
tbpA3. Transcription of murF and pptA was carried out using the primer pairs
murF5-murF3 and pptA51469- pptA31706, respectively. Negative controls
without reverse transcriptase were performed in parallel.
Sample preparation and infusional MS analysis of intact PilE. Pilus purifi-
cation was carried out as described previously (66), and preparations were
further processed using a methanol/chloroform precipitation procedure (1, 62).
All data were acquired on a quadrupole time-of-flight mass spectrometer (Q-Tof
micro; Micromass, Manchester, United Kingdom) equipped with the standard
Z-spray electrospray ionization (ESI) source as described previously (1).
RESULTS
Genetic characterization of pptA. pptA maps upstream of
murF, whose product is required for synthesis of UDP-
MurNAc pentapeptide, a precursor essential to peptidoglycan
synthesis (45). When the genetic organization of this locus was
examined by transposon mutagenesis, only four of the nine
insertions constructed in E. coli were recoverable in strain
N400 (Fig. 1A). Moreover, transposon insertion mutants 9 and
11 uniquely displayed aberrant cell septation and “giant” cell
morphology phenotypes that were paralleled by unusual colony
morphologies and poor growth properties (Fig. 1B and C).
Steady-state levels of murF mRNA were significantly reduced
in the Tn9 and Tn11 backgrounds, slightly less diminished in
the Tn22 mutant, and surprisingly elevated in the Tn5 back-
ground (Fig. 2A). Unlike the kanamycin resistance gene cas-
sette insertion mutant (in which the level of murF mRNA was
indistinguishable from the wt background), all four of the
transposon insertion mutants displayed abnormal levels of
murF mRNA.
PilE phospho-form modification was abolished in back-
grounds in which transposon insertions disrupted the pptA
open reading frame (ORF) (Tn5, -9, and -11) (data not shown)
and reduced in that carrying the insertion upstream of the pptA
ORF (Tn22) (Fig. 2B and C). These findings were consistent
FIG. 1. Mapping and phenotypic characterization of pptA-linked
transposon insertion mutants. (A) Physical map of the gonococcal pptA
locus with transposon insertions indicated by circles. F, transposon
insertions that could not be recovered in N. gonorrhoeae; E, insertions
with wt growth phenotype. The red circles represent transposon inser-
tions that resulted in aberrant cell septation and coccal morphology.
The precise sites of transposon insertion are shown in Fig. S1 in the
supplemental material. The striated box defines the Pfam PF00884
sulfatase domain of PptA. (B) Cell septations and coccal morphologies
of transposon mutants detected by immunofluorescence microscopy.
Gonococci were detected using fluorescein-labeled MAbs (green).
(C) Gonococcal colonies on conventional medium showing the differ-
ent growth phenotypes of transposon mutants. The strains used were
wt (N400), pptA::kan (KS9), Tn22 (pptA::Tn22; KS8), Tn5 (pptA::Tn5;
KS5), Tn9 (pptA::Tn9; KS6), and Tn11 (pptA::Tn11; KS7).
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with our earlier work documenting the requirement for PptA
in phospho-form modification (1). However, complementation
there employed an ectopic, intact pptA gene copy (encompass-
ing the pptA ORF and 420 bp of upstream sequence) that
failed to restore phospho-form modification to levels seen in
the wt background. Based on a real-time RT-PCR assay,
complementation with the ectopic pptA gene copy restored
pptA mRNA detection in a pptA::kan background, but not to
levels seen in the wt background (Fig. 3). These studies were
carried out in a pilV null background that enhanced PptA-
mediated modification and led to PC decoration in order to
facilitate phospho-form analyses and quantification. It is im-
portant to note, however, that pptA mRNA levels in a pilV
background were not significantly altered from those seen in a
wt background (Fig. 3, lane 2).
To provide higher levels of pptA for complementation, an
inducible pptA allele carrying a tandem lac operator-promoter
sequence was placed in the iga locus. In its repressed state, no
mRNA was detected (data not shown), while when maximally
derepressed, mRNA levels 17-fold higher than those seen for
the wt strain were observed (Fig. 3, lane 6). Using a pptA::kan
pilV background (KS11), a clear correlation was observed be-
tween levels of inducer, PptA protein, and the PilE PC epitope
(as assessed by reactivity with the PC epitope recognizing
TEPC-15 MAb) to a point where PC epitope levels plateaued
while PptA levels increased (Fig. 4A). MS analyses of intact
PilE protein from purified Tfp confirmed that increasing pptA
expression was paralleled by concomitant increases in PE and
PC site occupancy (Fig. 4B to D). Despite the high levels of
pptA mRNA seen when maximally derepressed, detection of
the pilin PC epitope remained dependent on the absence
of PilV and was not seen under any conditions in the presence
of the wt pilV allele (data not shown).
While transformants bearing Tn7 and Tn23 were not recov-
erable in a wt background, they could be established in a pptA
diploid background (data not shown), and in all these in-
stances, the insertions mapped to the ectopic gene copy. To-
gether, these results are consistent with the hypotheses that (i)
pptA and murF are part of a single transcriptional unit whose
FIG. 2. PptA-linked transposon insertion mutations perturb murF
expression and PptA activity. (A) Real-time RT-PCR analysis of murF
mRNA levels in mutants carrying transposon insertions. Amplification
of tbpA (5) served as an internal reference and control. Negative
controls were performed without reverse transcriptase treatment (not
shown). The values are means 	 standard errors of the mean; n 
 3.
The strains used were wt (N400), pptA::kan (KS9), Tn22 (pptA::Tn22;
KS8), Tn5 (pptA::Tn5; KS5), Tn9 (pptA::Tn9; KS6), and Tn11
(pptA::Tn11; KS7). The Tn22 mutation reduces PilE phospho-form
modification. (B and C) Intact mass analysis of PilE N400 (wt) (B) and
KS8 (pptA::Tn22) (C). Species labeled as bearing PE/PC modifications
also carry the hexose-2,4-diacetamido-2,4,6-trideoxyhexose (Hex-
DATDH) dissacharide in its acetylated form. Peaks in the MS spectra
that are not labeled are listed in Table S3 in the supplemental material.
FIG. 3. Relative pptA mRNA levels in defined isogenic back-
grounds. Real-time RT-PCR amplification of tbpA mRNA (5) served
as an internal reference/control. Negative controls included reactions
performed without reverse transcriptase; no products were detected
under these conditions (not shown). The values are means 	 standard
errors of the mean; n 
 3. Bars: 1, wt (N400); 2, pilV(Fs) (GV1); 3,
pilV(Fs) pptA::kan (KS10); 4, pilV(Fs) pptA::kan iga::pptA (KS27); 5,
pilV(Fs) iga::pptA (KS26); 6, pilV(Fs) pptA::kan iga::pptA(Ind) (KS11)
induced with 0.25 mM IPTG. pptAwt and pptAiga refer to pptA allele
status, with the gene at either the endogenous locus (wt) or the ectopic
locus (in iga). ind., ectopic, inducible pptA in its derepressed state.
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promoter maps at least 400 bp upstream of the pptA ORF, (ii)
the growth defects seen in some pptA transposon mutants are
the result of perturbed cell wall metabolism ensuing from re-
duced levels of MurF and are not directly related to altered
PptA expression, and (iii) the pilV null allele does not lead to
increased pptA transcription.
Pilin PC modification does not require exogenous choline.
Both the phosphatidylcholine synthase- and lic gene-based
pathways require exogenous choline as a precursor (46). Al-
though neither pathway has been documented in pathogenic
Neisseria species, we nonetheless tested if the pilin PC modi-
fication occurred in the absence of exogenous choline by grow-
ing the bacteria on chemically defined, choline-free medium
(30). As seen by pilin reactivity with the TEPC-15 MAb for a
pilV strain, PC modification occurred independently of an
exogenous choline source (Fig. 5). Surprisingly, PC modifica-
tion of pilin was seen for the first time in a wt background when
propagated in defined, choline-free medium. Moreover, PC
modification was PptA dependent under these conditions and
was not detectable when a strain expressing PilE carrying an
alanine substitution in place of serine at position 68 (the major
residue for phospho-form modification) was used. To examine
pilin phospho-form modifications occurring under these
growth conditions in more detail, MS analysis of intact pilin
was performed. In contrast to the sample derived from growth
in conventional medium, one of the major species detected
corresponded to PilE bearing the modified disaccharide and
no phospho-form (Fig. 6A and B). Along with signals corre-
sponding to glycosylated PilE carrying either one or two PE
moieties, species corresponding to PilE bearing the modified
disaccharide and a single PC and PilE bearing the modified
disaccharide, one PE, and one PC were found in this sample.
The signals for PilE derived from the pilE(S68A) strain grown
in choline-free medium were not notably different from those
observed previously for that mutant propagated in conven-
tional medium (Fig. 6C). Given the unique finding of PC mod-
ification in a wt background, the status of PilV expression was
assessed. In all backgrounds, PilV levels in cells cultured in
defined, choline-free medium were reduced two- to threefold
relative to levels seen in samples from conventional medium
(Fig. 5, bottom). These findings demonstrate that the PilE PC
moiety can be endogenously synthesized and corroborated ear-
lier data showing that PC modification is associated with di-
minished PilV expression.
Comparative modeling of the putative catalytic domain of
PptA. PptA shares basic structural features with LPS PE trans-
ferases, including an N-terminal contiguous region containing
five consecutive transmembrane domains and a large sulfatase
FIG. 4. PilE PC modification levels parallel regulated expression of
PptA. (A) Lane 1 (from left), KS9 (pptA::kan); lane 2, KS11 without
IPTG [pilV(Fs pptA::kan iga::pptA(Ind)]. Lanes 3 to 9, KS11 with IPTG
in the following concentrations: lane 3, 0.01 mM; lane 4, 0.015 mM;
lane 5, 0.02 mM; lane 6, 0.03 mM; lane 7, 0.04 mM; lane 8, 0.05 mM;
lane 9, 0.1 mM; lane 10, control (GV1). (B to D) Deconvoluted
molecular weight spectra from intact PilE ESI MS analyses in strains
KS11 without IPTG [pilV(Fs) pptA::kan iga::pptA(Ind)] (B), KS11 with
IPTG (0.015 mM) (C), and KS11 with IPTG (0.250 mM) (D). Species
labeled as bearing PE/PC modifications also carry the hexose-2,4-
diacetamido-2,4,6-trideoxyhexose (HexDATDH) dissacharide in its
acetylated (ac) form. A complete list of m/z forms and corresponding
species of PilE can be found in Table S3 in the supplemental material.
Asterisks indicate samples in which pptA was induced with 0.015 mM
IPTG (A and C).
FIG. 5. PilE PC modification occurs in a wt background when
propagated in defined, choline-free medium. (Top) Immunoblot of
whole-cell lysates using polyclonal antibodies specific for PilE. (Mid-
dle) MAb TEPC-15 specific for PC. (Bottom) Polyclonal antibodies
specific for PilV. N. gonorrhoeae strains were grown either on solid
conventional medium (C) or on solid defined, choline-free medium
(D). Lanes: 1 and 2, wt (N400); 3 and 4, pilV(Fs) (GV1); 5 and 6,
pptA::kan (KS9); 7 and 8, pilE(S68A) (GE68).
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domain of the Pfam PF00884 family. Based on topological
studies of PmrC, the sulfatase domain is predicted to be ori-
ented in the periplasm (24). Included within the PF00884 do-
main family are the catalytic sites of members of the alkaline
phosphatase superfamily of metalloenzymes as defined on the
basis of biochemical and X-ray structural studies (2, 21, 36).
We structurally modeled the PptA sulfatase domain to assess
the similarities of its potential catalytic core to known protein
structures. Although modeling with the CPHmodels and Swiss-
Model programs failed to give significant hits, two models of
significance were found using the ModWeb Modeler server
(32) (Fig. 7A and B). These high-quality models derived from
the human arylsulfatases ArsA and N-acetylgalactosamine-4-
sulfatase both predicted prototypic / topology consisting of
a central core of -strands circumferentially flanked by -
helices. Moreover, putative metal-binding residues predicted
previously (11, 12) (H374, H379, D435, and H436) were well
colocalized, and there was remarkable conservation in their
spatial positioning relative to the active-site structures of other
alkaline phosphatase superfamily members. While not pre-
cisely superimposable on the structures of the other enzymes,
the results strongly suggest that PptA possesses the same
highly conserved catalytic core structure and therefore acts
through a similar catalytic mechanism. If true, a nucleophile
would likely be present in the vicinity of the metal coordination
residues, and here, the hydroxyl of S241 is a good candidate. It
is important to specify here that despite their overall congru-
ence, the two models differ, with the ArsA-based model being
comprised of six central -strands while the N-acetylgalac-
tosamine-4-sulfatase-based model has five central -strands.
This discrepancy influences the positioning of another putative
active-site nucleophile (T278), which coordinates only with the
other residues of the putative catalytic domain in the model
based on ArsA.
Site-directed mutagenesis of putative active-site residues in
PptA. The modeled structures of the PptA active site and the
inferred mechanism of activity predicted that a number of
amino acid residues were likely to be of significant importance
to enzyme catalysis. We also assessed the degrees of conser-
vation of these candidate residues within the LPS PE trans-
ferase family (previously described as the YhjW/YjdB/YijP
family), as found in Prodom entries PD005703 and PD461453,
which encompass S241, H374, H379, D435, and H436 (Fig. 8).
PptA, all known LPS PE transferases (excluding those related
to Lpt6-type enzymes), and over 100 other uncharacterized
proteins possess the PD005703 defined domain. All of these
proteins carry readily identifiable, highly conserved residues
corresponding to S241 (serine or threonine) and conserved
residues corresponding to H374 and H379. Likewise, PptA and
all known LPS PE transferases (excluding those related to
Lpt6-type enzymes) and over 100 other uncharacterized pro-
teins possess the PD461453 defined domain, including con-
served residues corresponding to D435 and H436. Other abso-
lutely conserved residues are seen in proteins bearing the
PD005703 and PD461453 defined domains, and very often,
these map adjacent to the residues noted above. To test the
relevance of the PptA models and the significance of putative
active-site residues, alanine substitution mutations for those
residues modeled as being in the active site, along with certain
conserved flanking residues, were constructed and introduced
into a pilV null background. This background facilitated screening
of the mutants for PptA function by virtue of PilE reactivity with
the TEPC-15 MAb recognizing the PC epitope and the reduction
in PilE mobility associated with phospho-form modification. As
shown in Fig. 9, three of the nine pptA missense mutations (H379,
D435, and H436) resulted in the pptA null phenotypes seen as loss
of reactivity with the TEPC-15 MAb and increased PilE mobility
in SDS-PAGE. MS analysis of intact PilE confirmed the absence
of PC and PE modified forms (see Fig. S2 in the supplemental
material and data not shown). In contrast, mutation of neighbor-
ing residues (G377, S378, and S434) had no observed effect on these
PptA phenotypes. Mutants with alanine substitutions at either
S241 or H374 retained TEPC-15 MAb reactivity and retarded PilE
migration (Fig. 9). However, MS analyses of intact pilin from
these two backgrounds were consistent with phospho-form hypo-
modification and showed pilin subunits exclusively modified with
a single PC moiety (see Fig. S2 in the supplemental material).
Finally, deleting residue S241 resulted in a pptA null phenotype, as
seen by MS analysis of intact pilin and reaction to TEPC-15 MAb,
although expression of PptA was normal (Fig. 9 and data not
FIG. 6. MS analysis of intact PilE from N. gonorrhoeae strains grown
in defined, choline-free medium. (A) Wt (N400) grown on solid conven-
tional medium. (B) Wt (N400) grown on solid defined, choline-free me-
dium. (C) pilE(S68A) (GE68) grown on solid defined, choline-free me-
dium. The species labeled as bearing PE/PC modifications also carry the
hexose-2,4-diacetamido-2,4,6-trideoxyhexose dissacharide (HexDATDH)
in its acetylated (ac) form. The peaks in the MS spectra that are not
labeled are listed in Table S3 in the supplemental material.
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shown). The residues shown here to impact on PptA activity are
illustrated in the context of the modeled active-site structures
based on arylsulfatase A and N-acetylgalactosamine-4-sulfatase
(see Fig. S3 in the supplemental material).
Potential implications for the Lpt6 subfamily of LPS PE
transferases and MdoB. PE modifications at position 6 of
inner core heptose II of LPS in H. influenzae and some strains
of N. meningitidis involve a unique family of putative trans-
ferases termed Lpt6 (19, 70). Despite their high degree of
identity to one another, H. influenzae and N. meningitidis Lpt6
were reported to have an extremely limited degree of related-
ness to PptA and the other putative LPS PE transferases. This
situation is mirrored in the fact that although the Lpt6 proteins
share the sulfatase domain of the Pfam PF00884 family and
analogous transmembrane domains of other LPS PE trans-
ferases, they lack the PD005703 and PD461453 defined do-
mains (Fig. 8). A previous sequence comparison of the two
Lpt6 proteins against Lpt3 and LptA aligned only 3 residues
FIG. 7. Comparative modeling of the catalytic domain of PptA. (A) (Top) Crystallographic structure of human N-acetylgalactosamine-4-
sulfatase (residues 43 to 533; Protein Data Bank [PDB] no. 1fsu). (Bottom) Three-dimensional structure of the sulfatase domain of PptA (residues
230 to 540) based on comparative modeling with 1fsu (sequence identity, 15%; E value, 1e-16; model score, 1.00). (B) (Top) Crystallographic
structure of human arylsulfatase A (residues 19 to 503; PDB no. 1auk). (Bottom) Three-dimensional structure of the sulfatase domain of PptA
(residues 230 to 547) based on comparative modeling with 1auk (sequence identity, 14%; E-value, 6e-42; model score, 0.90). Color coding of the
protein backbone is as follows: red, -helices; blue, -strands; gray, loop regions. Color coding for residues is as follows: yellow, residues involved
in metal ion coordination (human N-acetylgalactosamine-4-sulfatase, D53, D54, D300, and N301; arylsulfatase A, D29, D30, D281, and N282); cyan,
active-site residues (human N-acetylgalactosamine-4-sulfatase, C91; arylsulfatase A, C69). Yellow, analogous residues in PptA, i.e., putative residues
involved in metal ion coordination (H374, H379, D435, and H436); cyan, putative active-site residues (S241 and T278).
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common to all four (corresponding to Y432, D435, and H436 of
PptA) out of the total of 14 that are conserved in all proteins
with the PD005703 and PD461453 defined domains (70). An-
other work concluded that Lpt6 “had no significant amino acid
homology with the Lpt3 family proteins” (19). Rather, Lpt6
proteins are characterized by the PD883089 and PD144483
entries that nonetheless map within their Pfam PF00884 do-
mains. By juxtaposing the PD005703 and PD883089 domains
in reference to the common PF00884 sulfatase domain, it be-
comes obvious that the Lpt6 proteins have well-conserved,
similarly positioned residues corresponding to those identified
in the PptA/LPS PE transferases (Fig. 8). For example, 33 of
34 proteins possessing the PD144483 domain have a histidine
residue juxtaposable to PptA H379, and all 34 have the DH
residues (equivalent to PptA D435 H436) 60 to 70 residues distal
to it. Parenthetically, it is intriguing to note that over half of the
PD144483 domain-bearing proteins are from gram-positive or-
ganisms. This finding may give some insight into the evolution-
ary origins of Lpt6 PE transferases.
The same analysis used for Lpt6 was applied to MdoB, a
member of the periplasmically localized phosphoglycerol
transferase family that catalyzes the addition of phosphoglyc-
erol to membrane-derived oligosaccharides from phosphatidyl-
glycerol (17). This protein and its orthologues also possess the
Pfam PF00884 domain but are uniquely defined by the
FIG. 8. Alignment of sulfatase domains from the PptA/LPS PE transferase protein family. (A) Graphical overview of the domain structure of
PptA. Color codes: orange, signal peptide (residues 1 to 33) with a hidden transmembrane region (residues 13 to 32); red, transmembrane regions
(residues 42 to 61, 68 to 90, 122 to 144, and 156 to 175); green, sulfatase domain PF00884 (residues 230 to 516); blue, Prodom families PD005703
and PD461453; pink, Prodom families PD883089 and PD144483 (found in Lpt6); yellow, Prodom families PD605628 and PD698194 (found in
MdoB). The domain structures are similar for all the proteins belonging to Prodom families PD005703 and PD461453. (B) Juxtaposed alignment
of the sulfatase domain-containing proteins from Prodom family PD005703. Color codes: red, absolutely conserved residues; green, either S or T;
blue, residues conserved only between characterized proteins. Lpt6 is part of the Prodom families PD883089 and PD144483, as indicated by the
pink coloring of the residues. MdoB is part of the Prodom families PD605628 and PD698194, as indicated by the yellow coloring of the residues.
(C) Alignment of characterized proteins from Prodom family PD461453. The color coding is the same as in panel B. The aligned proteins are as
follows: PptA, Q9RMJ3 NEIGO; LptA, Q7DD94 NEIMB; Lpt3, Q9JXJ7 NEIMB; EptB, Q38J80 ECOLI (formerly YhjW); PmrC, YjdB SALTY;
CptA, Q7CPC0 SALTY; Lpt6, Q9JWE8 NEIMA; MdoB, P39401 (OPGB) ECOLI.
FIG. 9. PptA activities in structure-based, site-directed PptA mutants.
(Top) Immunoblot of whole-cell lysates using polyclonal antibodies specific
for PptA. (Middle) Polyclonal antibodies specific for PilE. (Bottom) MAb
TEPC-15 specific for PC. Lanes: control, pilV(Fs) (GV1); pptA::kan, pilV(Fs)
pptA::kan (KS10); G239A, G239A (KS18); S241A, S241A (KS16); S241,
S241 (KS17); H374A, H374A (KS19); G377A, G377A (KS20); S378A,
S378A (KS21); H379A, H379A (KS22); S434A, S434A (KS23); D435A,
D435A (KS24); H436A, H436A (KS25). As controls for all mutants, immu-
noblotting was used to ensure that reduced or absent phospho-form modifi-
cation did not result from decreased PptA stability.
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PD605628 and PD698194 domains. By juxtaposing these do-
mains in reference to the shared sulfatase domain, MdoB and
related proteins have conserved, similarly positioned residues
corresponding to those identified in the PptA/LPS PE trans-
ferases. Here, 29 of 33 proteins possessing the PD698194 do-
main have a histidine residue juxtaposable to PptA H379, while
13 of 33 have the DH residues (equivalent to PptA D435 H436)
60 to 70 residues distal to it. The latter value is misleadingly
low due to the fact that the DH signature is at the very end
of the domain, and manual inspection shows that over half
of the PD698194 domain-bearing proteins actually have sim-
ilarly positioned DH residues. The striking conservation of
putative active-site residues for all these likely phospholipid
head group transferases strongly suggests that each involves
the same reaction mechanisms defined for better-character-
ized members of the phospho-/sulfo-coordinating met-
alloenzymes.
PilE phospho-form modification in heterologous host spe-
cies. As another approach to probing the relationship between
PE and PC PilE modifications, we expressed both N. gonor-
rhoeae PptA and PilE in P. aeruginosa. Unlike the case in
pathogenic Neisseria species, phosphatidylcholine is an estab-
lished phospholipid constituent in P. aeruginosa, with a well-
characterized phosphatidylcholine synthase biosynthetic path-
way (63). Here, the relaxed specificity of the P. aeruginosa pilus
assembly machinery made it possible to carry out MS analyses
of intact PilE from purified Tfp. In the presence of PptA, the
sole species observed in the mass spectrum of intact PilE cor-
responded to the mature protein modified with two PE moi-
eties, while in its absence, a single signal reflecting unmodified
PilE was found (Fig. 10A and B). Coexpression of PptA and
PilE with an alanine substitution at S68 showed two signals
corresponding to unmodified PilE and PilE with a single PE
attached (Fig. 10C). Save for the absence of glycan-related
species, these findings were remarkably similar to those seen
for this altered PilE derived from N. gonorrhoeae. Moreover,
given the stoichiometry of PE site occupancy in the wt and S68
mutant PilE evidenced by the signals seen from P. aeruginosa-
derived samples, the heterologous system recapitulates the
hierarchical nature of PE modification seen in N. gonorrhoeae,
with modification at S68 significantly increasing the likelihood
that a second site will be modified (1). The hierarchical nature
of PilE PE modification is thus an intrinsic property of the
substrate and enzyme.
To confirm that the PilE species seen in the top-down MS
analysis reflected the major forms expressed in P. aeruginosa,
immunoblotting of whole-cell lysates was performed. As seen
in Fig. 10D, migration of wt PilE expressed in conjunction with
PptA was clearly retarded relative to its unmodified form,
while the mobility of the S68 mutant PilE was intermediate
between those of unmodified and modified forms of wt PilE.
The mobilities of wt PilE coexpressed with and without PptA
in E. coli were also examined by immunoblotting, and again, a
significant PptA-dependent reduction in mobility was seen.
Finally, these samples were also probed with the PC epitope
recognizing TEPC-15 MAb with negative results (data not
shown). Thus, PptA alone is sufficient for pilin modification
with PE in P. aeruginosa and appears to have a similar activity
when expressed in E. coli. However, there was no evidence for
PilE PC modification in P. aeruginosa under the same condi-
tions, despite the availability of the potential precursor phos-
phatidylcholine, as well as functional pathways for phosphati-
dylcholine biosynthesis.
FIG. 10. PptA-mediated PilE modification in P. aeruginosa and E. coli. (A) MS analysis of intact PilE expressed in P. aeruginosa. (B) MS
analysis of intact PilE coexpressed with PptA in P. aeruginosa. (C) Intact mass analysis of a PilE(S68A) mutant coexpressed with PptA in P.
aeruginosa. (D) Immunoblot of whole-cell lysates using polyclonal antibodies specific for PilE. Lanes 1 to 3 (from left), P. aeruginosa pilA pilT
expressing N. gonorrhoeae proteins: lane 1, PilE; lane 2, PilE(S68A); lane 3, PilE and PptA. Lanes 4 and 5, E. coli DH5 expressing the proteins:
lane 4, PilE; lane 5, PilE and PptA. Peaks in the MS spectra that are not labeled are listed in Table S3 in the supplemental material.
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DISCUSSION
Accumulating evidence suggests that the decoration of
microbial surfaces with PE and PC moieties is a surprisingly
common and important factor in host-parasite interactions.
However, the biosynthetic pathways and enzymes that gener-
ate the modified PE and PC molecules presented on microbial
surfaces are poorly understood. In this study, we addressed
several outstanding questions regarding PptA and pilin phos-
pho-form modification biology. Lacking in vitro assays for pilin
phospho-form modification activity, we focused on genetic
characterization of pptA as a means to probe the relationships
between PptA expression, structure, and function, as well as
the mechanisms by which other factors impact the system. In
addition to confirming the role of PptA in pilin phospho-form
modification, phenotypes associated with transposon muta-
tions mapping upstream and in its ORF show that pptA ex-
pression is tightly coupled to that of murF and that MurF is
undoubtedly an essential protein. Taken together with the low
levels of pptA mRNA and PptA activity imparted by an ectopic
allele containing 420 bp 5 of the ORF, murE, pptA, and murF
are likely part of a single operon whose promoter precedes
mraZ (28). This finding is interesting because pptA expression
in N. meningitidis has been shown to undergo phase variation
due to frameshifting within a monotonous stretch of nucleo-
tides (58). Such a pptA regulatory system is one of the few, if
not the only, genetic control mechanisms compatible with its
polycistronic organization that would not disturb distal murF
expression. Based on the unperturbed murF expression seen
for the pptA::kan allele, this background was used to show a
dose-dependent relationship between PptA and pilin phospho-
form modification and full stoichiometric restoration of phos-
pho-form site occupancy. It is important to note here that
although PC substitution may be an indirect readout of PptA
activity (see below), assays to detect the PC epitope are more
sensitive and quantitative for monitoring pilin modification at
low to moderate PptA levels than MS detection of the PE
substituent.
Galperin et al. and Galperin and Jedrzejas (11, 12), first
noted the pattern of sequence similarities between phospho-
pentomutases, cofactor-independent phosphoglycerate muta-
ses, alkaline phosphatases, and sulfatases defining the alkaline
phosphatase superfamily. Encompassed within the catalytic
core structures for each are similarly located serine and threo-
nine (and cysteine in sulfatases) residues shown to form the
covalent intermediates and residues implicated as metal-bind-
ing and coordinating sites. Included in that early analysis were
EptB, PmrC, CptA, and orthologous proteins from H. influen-
zae, but at that time, their functions were not known. The
relevance of those findings to establishing structural and cata-
lytic similarities between PptA and the other alkaline phos-
phatase superfamily members was first demonstrated here by
molecular modeling, with high-quality models derived using
human lysosomal sulfatases predicting a striking colocalization
of putative active-site and metal-coordinating residues. The
significance of these findings was further validated by mutagen-
esis with individual substitution mutations of three residues
implicated in metal coordination abolishing PptA activity,
whereas that of a fourth such residue diminished activity. Ala-
nine substitution at a highly conserved serine potentially cor-
responding to the catalytic residue (S241) reduced PptA activ-
ity. While this result might imply that S241 is not the site of
formation of a covalent intermediate, the loss of the phosphor-
ylatable hydroxyl group nucleophile might be compensated for
by a water molecule, as shown for catalytic residue S102 sub-
stitution mutants of AlkP (48). The idea that active-site archi-
tecture (together with an appropriate nucleophile source)
might contribute to catalysis is further attested to by the com-
plete lack of activity seen for the S241 mutant. Nonetheless, at
this point, we cannot rule out the importance of a highly
conserved T278 as an active-site residue. Potentially highly con-
served residues synonymous with those implicated in PptA
catalysis are readily identifiable within the Prodom PD005703
and PD461453 domains defining the LPS PE transferase family
members, the Prodom PD883089 and PD144483 domains in
the Lpt6 LPS PE transferase family members, and even the
Prodom PD605628 and PD698194 domains defining MdoB
phosphoglycerol transferase family members. Accordingly, the
conserved structure and modular organization of these en-
zymes clearly attest to common sites of action and conserved
reaction mechanisms.
The bulk of evidence supports the hypothesis that PptA is a
PE transferase that utilizes the phospholipid head group of
phosphatidylethanolamine as a donor. To date however, utili-
zation of phosphatidylethanolamine as a precursor for PE has
been demonstrated only for EptB (35), N. gonorrhoeae Lpt3
(31), and modifications of membrane-derived oligosaccharides
(17). The enzyme responsible for the last activity is unknown,
although the enzyme MdoB (which catalyzes the addition of
phosphoglycerol derived from phosphatidylglycerol to mem-
brane-derived oligosarcharides) has been ruled out (29). As-
suming phosphatidylethanolamine is the precursor to PptA-
mediated modifications, the question of what the precursor for
PC is remains a perplexing problem. We previously proposed
two plausible scenarios, one in which PptA might utilize phos-
phatidylcholine as a head group donor and another in which
PptA would decorate PilE with PE that would be modified in
situ into PC by the action of PE methyltransferase(s) (1). The
phosphatidylcholine donor model is challenged by a number of
observations. First, the presence of phosphatidylcholine in N.
gonorrhoeae remains unsubstantiated. Second, the activities
and active-site architecture of alkaline phosphatase superfam-
ily enzymes are quite specific, and the ability of PptA to ac-
commodate PE, as well as PC, with its additional trimethylam-
monium group, would likely require a high degree of relaxed
specificity. Third, PC modification is not seen, even in the
phosphatidylcholine possessing P. aeruginosa background de-
spite high levels of PptA-mediated PE site occupancy. Finally,
well-characterized structural modules and domains implicated
in PC recognition or binding, such as those seen in PC esterase
(15), CRP (54), phospholipase C (27), and pneumococcal cho-
line binding proteins (8), are not readily recognizable in PptA
(data not shown). An alternative model invoking methylation
of PE bound to pilin is also problematic, as this would un-
doubtedly have to occur in the periplasm and the methyl donor
S-adenosylmethionine is unlikely to be available at this site.
Nonetheless, we have targeted potential N. gonorrhoeae PE
methyltransferase homologs identified using the criteria de-
tailed previously (46) for mutagenesis. However, the results are
equivocal, since in some cases it has not been possible to
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recover null mutants, while in those cases where knockouts
were viable, PC modification was not altered. Further evalua-
tion of the alternative models would be dramatically facilitated
by high-resolution structural analysis of the PptA sulfatase
domain. Likewise, the availability of the PE pilin modification
system in P. aeruginosa and E. coli should provide unique
opportunities for both biochemical and genetic screens for
PC-generating activities.
The relationships between PE and PC modifications are
further complicated by the influence of the PilV pilin-like
protein. Both PE hypermodification and PC modification are
associated with pilV null backgrounds, and conversely, phos-
pho-form hypomodification has been demonstrated in pilV-
overexpressing backgrounds. However, levels of pptA mRNA
are not discernibly elevated in a pilV null background, and
overexpression of pptA does not in and of itself lead to PC
modification in either N. gonorrhoeae or P. aeruginosa. Con-
versely, PC modification is seen even at low levels of pptA
expression, provided that PilV is not present. Therefore, PilV
does not impact on the system by modulating levels of PptA
but rather may influence PptA activity or PC donor availability.
It is interesting to note here that there is evidence in related
periplasmic, phospholipid head group transferase systems that
enzyme activity can be dramatically influenced by environmen-
tal signals. For example, the activity of E. coli EptB requires
elevated levels of Ca2 in a heptose-deficient mutant (35), PE
modification of N. meningitidis lipid A by LptA is reported to
be significantly influenced by growth conditions (6), and the
activity of MdoB phosphoglycerol transferase is regulated di-
rectly by osmolarity (20). Even in the case of the seemingly
unrelated system of lic1-mediated PC modification of LPS in
H. influenzae, it has been suggested that levels of PC modifi-
cation are influenced by growth conditions in a manner that
cannot be solely accounted for by alterations in lic1 mRNA
levels (69). It is therefore not without precedent that PptA
activity might be altered by environmental conditions, al-
though how PilV might be involved here is open to speculation.
Despite the findings made here, a considerable number of
facets of the systems remain to be explored. Is PptA dedicated
solely to pilin modification, or are other proteins modified?
This is a particularly daunting task, as protein PE modifications
are only recognizable through MS analyses. Likewise, do other
members of the PptA/LPS PE transferase family possess pro-
tein-modifying activity? And what structural features, domains,
and residues dictate the seemingly exclusive propensities for
most family members to target LPS while PptA modifies pilin?
Finally, there remains a serious gap in our knowledge of the
enzymes directly engaged in PC modification of molecules
elaborated on bacterial cell surfaces. In the case of PC modi-
fications of LPS and teichoic acid associated with lic genes, the
role of LicD as a PC transferase is inferred from genetic data
indicating that licD allele status influences the sites of PC
modifications in the target moieties (59, 71). Furthermore, the
enzymes involved in the incorporation of PC into certain pneu-
mococcal capsular polysaccharides are undefined (47). For-
mally, then, the enzymes that carry out the committed step of
PC modification have yet to be unambiguously identified in any
of these systems.
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